000			03916nam a22004815i 4500
999			_c200458663 _d76875
003			DE-He213
005			20231109085930.0
007			cr nn 008mamaa
008			220217s2022 sz | s |||| 0|eng d
020			_a9783030929381
024	7		_a10.1007/978-3-030-92938-1 _2doi
040			_aTR-AnTOB _beng _cTR-AnTOB _erda
060	0	0	_aWR 205
072		7	_aMJK _2bicssc
072		7	_aMED017000 _2bisacsh
072		7	_aMJK _2thema
096			_aWR205EBK
245	1	0	_aBiologic Therapy for Psoriasis _h[electronic resource] : _bCutting Edge Treatment Principles / _cedited by Nicholas Brownstone, Tina Bhutani, Wilson Liao.
250			_a1st ed. 2022.
264		1	_aCham : _bSpringer International Publishing : _bImprint: Springer, _c2022.
300			_a1 online resource
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
490	1		_aUpdates in Clinical Dermatology, _x2523-8892
505	0		_aIntroduction to Biologic Therapy for Psoriasis -- Laboratory Monitoring: TB, Hepatitis and HIV -- TNF-Alpha Class of Biologic Agents in Psoriatic Disease -- IL-17 class of Biologic Agents in Psoriatic Disease -- IL-23 Inhibition for the Treatment of Psoriatic Disease: Pathway Discovery and Overview -- Combination Therapy with Biologic Agents -- Biologic Agents for the Treatment of Pediatric Psoriasis -- Special Site Psoriasis -- Comparing Biologic Agents in Treatment of Psoriasis -- Long Term Registry Data for Psoriasis Biologics -- Psoriasis Biologic Agents in Special Populations -- Psoriasis Biologics and the COVID-19 Pandemic: Lessons Learned -- Adherence to Biologic Therapy for Psoriasis.
520			_aBiologic therapy is a treatment that strives to modulate a patient's immune system to fight a given disease. In psoriasis, a skin disorder that is partly caused by a dysregulated immune system resulting in well-demarcated red areas of the skin with white scales, biologic therapy has the potential to vastly improve upon patient outcomes by minimizing the symptoms of this disease while maximizing the safety profile of the therapy. This book offers an up-to-date and comprehensive review on biologic therapy for the treatment of psoriasis. With over 10 FDA approved biologic agents for psoriasis (with more in the pipeline), confusion exists among providers regarding which agent is best for a particular patient. Chapters cover all FDA approved psoriasis biologic agents (including pipeline agents) for use in pediatric, adult, and geriatric patients. This book is unique in that it will not only cover cutting edge treatment principles based on the latest research, it will also be one of the most comprehensive reviews of psoriasis biologics in the COVID-19 era. Biologic Therapy for Psoriasis is a must-have resource for board certified dermatologists and rheumatologists, dermatology and rheumatology residents and fellows, dermatology physician assistants, nurse practitioners and medical students. The ultimate goal of this book is to improve patient care by making the busy practicing dermatology provider more adept with these particular therapies.
650		0	_aDermatology.
650	1	4	_aDermatology.
700	1		_aBrownstone, Nicholas. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aBhutani, Tina. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aLiao, Wilson. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt
710	2		_aSpringerLink (Online service)
830		0	_aUpdates in Clinical Dermatology, _x2523-8892
856	4	0	_uhttps://doi.org/10.1007/978-3-030-92938-1 _3Springer eBooks _zOnline access link to the resource
942			_2NLM _cEBK
041			_aeng